Clinical Trial Update: Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

View source ↗

Summary

This completed clinical trial evaluated the effectiveness of existing anti-VEGF treatment regimens in patients with wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• BEOVU (BROLUCIZUMAB)
• EYLEA (Aflibercept)
• Lucentis (ranibizumab)

Snippet

Sponsor: Bayer | Conditions: Macular Degeneration | Status: COMPLETED